(Q30877100)

27 June 2017

Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration (English)

1 reference

27 June 2017

1 reference

1 reference

Flaxel CJ

1

1 reference

27 June 2017

Friedrichsen EJ

2

1 reference

27 June 2017

Smith JO

3

1 reference

27 June 2017

Oeinck SC

4

1 reference

27 June 2017

Blacharski PA

5

1 reference

27 June 2017

Garcia CA

6

1 reference

27 June 2017

Chu HH

7

1 reference

27 June 2017

1 April 2000

1 reference

27 June 2017

1 reference

27 June 2017

14 ( Pt 2)

1 reference

27 June 2017

155-164

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

27 June 2017

1 reference

Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

Radiation therapy for subretinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Radiation therapy for age-related subfoveal choroidal neovascular membranes. A pilot study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Interferon alpha 2a for treatment of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Vascular endothelial growth factor and the eye. Past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Hypoxic regulation of vascular endothelial growth factor in retinal cells

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2000.46

7 January 2021

Identifiers

DOI

10.1038/EYE.2000.46

1 reference

Dimensions Publication ID

27 June 2017

0 references

1 reference